Related Experiment Video
Updated: Jun 5, 2026
05:59
High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Alzheimer's disease: aging, insomnia and epigenetics
Tzong Yuan Wu1, Chih-Ping Chen, Tzyy-Rong Jinn
1Department of Bioscience Technology, Chung Yuan Christian University, Chung Li, Taipei, Taichung, Taiwan. tywu@cycu.edu.tw
Taiwanese Journal of Obstetrics & Gynecology
|January 5, 2011
Summary
Epigenetics may play a role in Alzheimer's disease (AD) development. New research suggests that insomnia could be a contributing factor to AD, highlighting the need for novel treatments.
Area of Science:
- Neuroscience
- Genetics
- Sleep Medicine
Background:
- Alzheimer's disease (AD) is the leading cause of dementia, characterized by memory loss and cognitive decline.
- Current treatments offer modest benefits, necessitating new therapeutic strategies.
- Understanding the underlying causes of AD is crucial for effective intervention.
Purpose of the Study:
- To review recent findings linking epigenetics to Alzheimer's disease.
- To explore the potential role of insomnia as a factor influencing AD progression.
- To identify new avenues for pharmacological development in AD treatment.
Main Methods:
- Review of current scientific literature on epigenetics and Alzheimer's disease.
- Analysis of studies investigating the relationship between sleep disturbances and cognitive function.
- Exploration of potential molecular mechanisms connecting epigenetic modifications, insomnia, and AD pathology.
Main Results:
- Emerging evidence suggests a significant connection between epigenetic alterations and the development of Alzheimer's disease.
- Insomnia is identified as a potential environmental factor that may influence AD pathogenesis.
- Existing pharmacological interventions for AD have limited efficacy, underscoring the need for innovative approaches.
Conclusions:
- Epigenetic mechanisms represent a promising area for understanding and potentially treating Alzheimer's disease.
- Further research into the interplay between insomnia and epigenetic factors is warranted.
- Novel therapeutic targets may emerge from investigating these complex biological relationships.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...